These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1745 related items for PubMed ID: 12546119

  • 21. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II, Shmelev EI.
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [Abstract] [Full Text] [Related]

  • 22. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S, Futsuki Y, Tomari S, Araki J.
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [Abstract] [Full Text] [Related]

  • 23. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M, Yosiyama T, Yosikawa M, Ogata H, Sugie T, Nakasono T, Sugita H.
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [Abstract] [Full Text] [Related]

  • 24. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE, Zierski M, Graczyk J, Bek E, Farer LS.
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [Abstract] [Full Text] [Related]

  • 25. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG, Lötter AP.
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [Abstract] [Full Text] [Related]

  • 27. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA, Ursov IG.
    Probl Tuberk Bolezn Legk; 2004 Nov; (3):21-6. PubMed ID: 15338895
    [No Abstract] [Full Text] [Related]

  • 28. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R, Al-Sharif N, Al-Sayegh MO, Osman MM, Shaikh MA.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [Abstract] [Full Text] [Related]

  • 29. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC, Lee YC.
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [Abstract] [Full Text] [Related]

  • 30. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T, Ogata H, Ito K, Aono A, Wada M.
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [Abstract] [Full Text] [Related]

  • 31. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
    Moulding TS, Le HQ, Rikleen D, Davidson P.
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
    [Abstract] [Full Text] [Related]

  • 32. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM, Bakare NA, Onadeko BO.
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [Abstract] [Full Text] [Related]

  • 33. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
    Harries AD, Gausi F, Salaniponi FM.
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):724-9. PubMed ID: 15182142
    [Abstract] [Full Text] [Related]

  • 34. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H.
    Arch Inst Pasteur Madagascar; 2002 Jun; 68(1-2):44-7. PubMed ID: 12643091
    [Abstract] [Full Text] [Related]

  • 35. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug 04; 37(954):67-70. PubMed ID: 7616907
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
    Tabarsi P, Baghaei P, Hemmati N, Mirsaeidi M, Kazempour M, Mansouri D, Masjedi MR.
    East Mediterr Health J; 2009 Aug 04; 15(6):1346-50. PubMed ID: 20218123
    [Abstract] [Full Text] [Related]

  • 40. Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
    Balasubramanian R, Nagarajan M, Balambal R, Tripathy SP, Sundararaman R, Venkatesan P, Paramasivam CN, Rajasambandam P, Rangabashyam N, Prabhakar R.
    Int J Tuberc Lung Dis; 1997 Feb 04; 1(1):44-51. PubMed ID: 9441058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 88.